Icatibant Injection, Solution
Product Images NDC 55150-351
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 55150-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure I (Icatibant Fig10)
Figure J (Icatibant Fig11)
Figure K (Icatibant Fig12)
Figure L (Icatibant Fig13)
Figure M (Icatibant Fig14)
Figure N (Icatibant Fig15)
Figure O (Icatibant Fig16)
Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syrine Label)
Icatibant is a medication available in the form of an injection. Each injection contains 30 mg of the active ingredient per 3 mL, with a concentration of 10 mg/mL. This injection is intended for subcutaneous use only. The medication comes in a single-dose prefilled syringe with a capacity of 3 mL. It is manufactured in India for Eugia US LLC, based in E. Windsor, NJ 08520. The code displayed is TS/DRUGS/13/2010.*
Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe Carton (1 Syringe))
This text appears to be from the packaging of a medication called Carlon. The medication is contained in a single-dose, prefilled syringe with a protective cap. It is indicated for subcutaneous use and each syringe delivers 30 mg of icatibant. The inactive ingredients include sodium chloride, glacial acetic acid, sodium hydroxide, and water for injection. The medication should be stored between 2° to 25°C and should not be frozen. The package insert contains full prescribing information, dosage, and administration instructions. The medication does not contain preservatives and the plunger rubber stopper is not made with natural rubber latex.*
Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe-Carton (3 Syringes))
Figure A (Icatibant Fig2)
Figure B (Icatibant Fig3)
Figure C (Icatibant Fig4)
Figure D (Icatibant Fig5)
Figure E (Icatibant Fig6)
Figure F (Icatibant Fig7)
Figure G (Icatibant Fig8)
Figure H (Icatibant Fig9)
Chemical Structure (Icatibant Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.